Ribeiro Marcia, Fanton Susane, Paiva Bruna R, Baptista Beatriz G, Alvarenga Livia, Ribeiro-Alves Marcelo, Cardozo Ludmila Fmf, Mafra Denise
Graduate Program in Nutrition Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil; Graduate Program in Biological Sciences - Physiology, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro (RJ), Brazil.
Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, RJ, Brazil.
Clin Nutr ESPEN. 2023 Feb;53:189-195. doi: 10.1016/j.clnesp.2022.12.009. Epub 2022 Dec 9.
Inflammation and oxidative stress lead to a high risk of cardiovascular disease in patients with chronic kidney disease (CKD). Food rich in polyphenols such as dark chocolate may be an effective strategy to mitigate inflammation and delay CKD complications, outwith sensorial pleasure promotion. The aim of this study was to evaluate the effects of dark chocolate on inflammation and oxidative stress markers in patients with CKD on hemodialysis (HD).
A clinical trial was carried out with 59 patients who were allocated into the chocolate group [40g of dark chocolate (70% cocoa) offered during HD sessions, 3×/week] or the control group with any intervention for two months. Plasma levels of the inflammatory cytokines TNF-α and IL-6 were evaluated by the ELISA method. Thiobarbituric acid reactive substances such as malondialdehyde (MDA) and LDLox levels were evaluated as lipid peroxidation markers. Routine biochemical parameters were analysed using commercial BioClin® kits.
Thirty-five patients completed the chocolate group (18 men, 53.0 (16) years and 31.0 (39) months on HD) and 11 in the control group (7 men, 48.0 (17.5) years and 44.0 (56.5) months on HD). Regarding the differences between the groups, the patients who received dark chocolate had reduced plasma levels of TNF-α compared to the control (p = 0.008). No significant changes were observed in the oxidative stress parameters evaluated in both groups. Routine biochemical (including phosphorus and potassium levels) and anthropometric parameters and food intake were not changed after the study period.
The intervention with dark chocolate (70% cocoa) for two months reduced the plasma levels of TNF-α in patients with CKD on HD. In addition, it is essential to emphasise that chocolate intake did not increase the plasma levels of phosphorus and potassium in these patients. This study was registered at clinicaltrials.gov as NCT04600258.
炎症和氧化应激会导致慢性肾脏病(CKD)患者患心血管疾病的风险升高。富含多酚的食物,如黑巧克力,可能是减轻炎症和延缓CKD并发症的有效策略,同时还能带来感官愉悦。本研究的目的是评估黑巧克力对接受血液透析(HD)的CKD患者炎症和氧化应激标志物的影响。
对59例患者进行了一项临床试验,这些患者被分为巧克力组[在HD治疗期间提供40克黑巧克力(可可含量70%),每周3次]或对照组,对照组在两个月内不进行任何干预。采用酶联免疫吸附测定(ELISA)法评估炎症细胞因子肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)的血浆水平。将丙二醛(MDA)等硫代巴比妥酸反应性物质和氧化型低密度脂蛋白(LDLox)水平作为脂质过氧化标志物进行评估。使用商用BioClin®试剂盒分析常规生化参数。
35例患者完成了巧克力组试验(18名男性,HD治疗时间为53.0(16)年和31.0(39)个月),11例患者完成了对照组试验(7名男性,HD治疗时间为48.0(17.5)年和44.0(56.5)个月)。关于两组之间的差异,与对照组相比,接受黑巧克力的患者血浆TNF-α水平降低(p = 0.008)。两组评估的氧化应激参数均未观察到显著变化。研究期结束后,常规生化指标(包括磷和钾水平)、人体测量参数和食物摄入量均未改变。
对接受HD的CKD患者进行为期两个月的黑巧克力(可可含量70%)干预可降低血浆TNF-α水平。此外,必须强调的是,巧克力摄入并未增加这些患者的血浆磷和钾水平。本研究已在ClinicalTrials.gov注册,注册号为NCT04600258。